Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Olanzapine augmentation of clozapine.

Literature DB >> 9781474

Olanzapine augmentation of clozapine.

Abstract

In clinical practice, patients are encountered who are partial responders or nonresponders to clozapine. There are others who are unable to tolerate a high dosage of clozapine. In the two cases presented, we propose an alternative strategy using olanzapine in combination with clozapine in treatment-refractory patients. Olanzapine was found to be helpful in these patients, however, controlled studies are needed.

Entities: Chemical Species

Mesh：

Substances：

Year: 1998 PMID： 9781474 DOI： 10.1023/a:1022350221192

Source DB: PubMed Journal: Ann Clin Psychiatry ISSN： 1040-1237 Impact factor: 1.567

Keyword Cloud
Cited

13 in total

1. Aripiprazole augmentation of clozapine: in refractory schizophrenia.

Authors: Adam Keller Ashton
Journal: Psychiatry (Edgmont) Date: 2005-02

2. Augmentation of olanzapine in treatment-resistant schizophrenia.

Authors: Mathias Zink
Journal: J Psychiatry Neurosci Date: 2005-11 Impact factor: 6.186

Review 3. Benefits and risks of antipsychotic polypharmacy: an evidence-based review of the literature.

Authors: Constantin Tranulis; Leila Skalli; Pierre Lalonde; Luc Nicole; Emmanuel Stip
Journal: Drug Saf Date: 2008 Impact factor: 5.606

4. Machine learning-based prediction of drug-drug interactions by integrating drug phenotypic, therapeutic, chemical, and genomic properties.

Authors: Feixiong Cheng; Zhongming Zhao
Journal: J Am Med Inform Assoc Date: 2014-03-18 Impact factor: 4.497

Olanzapine augmentation of clozapine.

1. Aripiprazole augmentation of clozapine: in refractory schizophrenia.

2. Augmentation of olanzapine in treatment-resistant schizophrenia.

Review 3. Benefits and risks of antipsychotic polypharmacy: an evidence-based review of the literature.

4. Machine learning-based prediction of drug-drug interactions by integrating drug phenotypic, therapeutic, chemical, and genomic properties.

Review 5. Augmentation strategies in clozapine-resistant schizophrenia.

Review 6. [Augmenting atypical antipsychotic medications with clozapin].

7. Clozapine: Current perspective.

8. Concept and Management of Treatment Resistant Schizophrenia (TRS).

9. [Atypical antipsychotics in therapy refractory schizophrenia].

10. Current perspectives in the treatment of resistant schizophrenia.